Integra Lifesciences Holdings (IART) Amortization - Intangibles (2009 - 2026)
Integra Lifesciences Holdings (IART) reported Amortization - Intangibles of $3.8 million for Q1 2026, up 1.94% on a YoY basis from $3.7 million in Q1 2025, and little changed sequentially from $3.8 million in Q4 2025.
Integra Lifesciences Holdings (IART) Amortization - Intangibles (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings (IART) has 18 years of Amortization - Intangibles data on file, last reported at $3.8 million in Q1 2026.
- For the quarter ending Q1 2026, Amortization - Intangibles rose 1.94% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $15.0 million (up 0.94% YoY), and the FY2025 full-year result was $15.0 million, down 29.76% from the prior year.
- Amortization - Intangibles steadied at $3.8 million in Q1 2026, from $3.8 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $10.1 million in Q1 2024 to a low of $3.0 million in Q2 2023.
- A 5-year average of $3.9 million and a median of $3.7 million in 2024 frame the typical range for Amortization - Intangibles.
- Across the five-year window, Amortization - Intangibles jumped 225.19% in 2024 and tumbled 63.35% in 2025, its largest moves.
- Tracing IART's Amortization - Intangibles over 5 years: stood at $3.5 million in 2022, then declined by 14.37% to $3.0 million in 2023, then increased by 22.45% to $3.7 million in 2024, then advanced by 1.43% to $3.8 million in 2025, then increased by 0.21% to $3.8 million in 2026.
- Business Quant data shows IART's Amortization - Intangibles at $3.8 million in Q1 2026, $3.8 million in Q4 2025, and $3.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Integra Lifesciences Holdings | 1.71 Bn | 1.45 Bn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.78 Mn |
| Dec 31, 2025 | 3.77 Mn |
| Sep 30, 2025 | 3.73 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Sep 30, 2024 | 3.76 Mn |
| Jun 30, 2024 | 3.71 Mn |
| Mar 31, 2024 | 10.11 Mn |
| Dec 31, 2023 | 3.03 Mn |
| Sep 30, 2023 | 3.21 Mn |
| Jun 30, 2023 | 3.03 Mn |
| Mar 31, 2023 | 3.11 Mn |
| Dec 31, 2022 | 3.54 Mn |
| Sep 30, 2022 | 3.14 Mn |
| Jun 30, 2022 | 3.30 Mn |
| Mar 31, 2022 | 3.89 Mn |
| Dec 31, 2021 | 4.08 Mn |
| Sep 30, 2021 | 4.11 Mn |
| Jun 30, 2021 | 4.20 Mn |